HCA Previews 2017 Third Quarter Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq hits intraday record high on Alphabet boost, Mideast negotiation hopes
- Exclusive: SB Energy Nasdaq IPO moving forward as planned
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Meta bull case increasingly playing out, Mizuho says
- Oil falls to two-week low as Gulf supply outlook improves
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
HCA Holdings (HCA) PT Lowered to $90 at Jefferies Following 3Q Pre-Announcement
October 19, 2017 8:48 AM EDTJefferies lowered its price target on HCA Holdings (NYSE: HCA) to $90.00 (from $92.00) while maintaining a Buy rating following the company's 3Q pre-announcement. HCA pre-announced Q3 EBITDA of $1.776B vs. $1.97B consensus. EBITDA was dragged down by the hurricanes ($140MM) and a TX Medicaid... More
